Latest In: marijuana epilepsy

GW Pharma aiming for FDA approval for CBD drug this year, again

British cannabis company GW Pharmaceuticals is hoping the U.S. Food and Drug Administration will sign off on its…

News January 26

Nabis CEO Vince Ning (Courtesy photo)

Nabis CEO on the future of interstate cannabis commerce post-rescheduling

Image of a Welcome to New Mexico sign

New Mexico built a successful cannabis market without the hype

Image of Asian doctor holding a tablet while talking with an African American patient

Will rescheduling revive medical cannabis? It depends on the state

Image of the Drug Enforcement Administration website on a laptop

DEA registration is a tough choice for medical marijuana operators

Image of a Welcome to Illinois sign

Illinois cannabis reform bill targets licensing gap, eyes federal future

Close-up image of a female doctor's hands

CMS is setting standards for what cannabinoid medicine looks like

1

The New Genetics Race: Why Cannabis Seed Brands Are Becoming the Next Big Differentiator

The Medical Card Has a New Argument

Leveling the Legal Playing Field

Hemp’s Regulatory Reckoning: A Patchwork States Can’t Sustain

Taking Your Business to the Next Level: The Ecommerce Maturity Scale

Taking Your Business to the Next Level: The Ecommerce Maturity Scale